Akebia Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

07.10.24	Akebia, U.S. Renal Care Enter Supply Contract; USRC Physicians To Prescribe Vafseo (RTTNews)
11.07.24	Akebia Therapeutics Issues Vafseo Commercial Launch Updates - Quick Facts (RTTNews)
28.03.24	Akebia's Vafseo Tablets Approved By FDA For Anemia Treatment In Dialysis Patients (RTTNews)
28.02.24	Biotech Stocks Facing FDA Decision In March 2024 (RTTNews)
25.10.23	Akebia Gets FDA Acceptance Of Resubmission To NDA Of Vadadustat For Treatment Of Anemia Due To CKD (RTTNews)
28.09.23	Akebia Therapeutics Resubmits NDA For Vadadustat To FDA (RTTNews)
25.08.23	Akebia Therapeutics Posts Loss In Q2; Net Product Revenue Down 2.5% (RTTNews)
24.08.23	Akebia Therapeutics Expects To Resubmit NDA For Vadadustat NDA In Q3 (RTTNews)
29.06.23	Akebia Announces Positive Topline Results From Phase 4 Study On Auryxia (RTTNews)
30.05.23	Akebia: FDA Denies Formal Dispute Resolution, But Provides Company Path Forward For Vadadustat (RTTNews)
23.05.23	These 14 Biotech Stocks Hit New Highs, Did You Get In Early? (RTTNews)
22.05.23	Akebia Therapeutics Announces UK MHRA Marketing Authorization For Vafseo (RTTNews)
03.04.23	Akebia Announces Positive Results From Vadadustat Alternative Dosing Study (RTTNews)
22.12.22	Akebia Receives Interim Response From FDA To Appeal For Vadadustat (RTTNews)
09.05.22	ROSEN, A LEADING LAW FIRM, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AKBA (PR Newswire)
29.04.22	ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important May 13 Deadline in Securities Class Action - AKBA (PR Newswire)
20.04.22	AKBA INVESTOR NOTICE: ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Akebia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AKBA (PR Newswire)
13.04.22	AKBA INVESTOR NEWS: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AKBA (PR Newswire)
06.04.22	ROSEN, A LEADING LAW FIRM, Encourages Akebia Therapeutics, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - AKBA (PR Newswire)
30.03.22	ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Akebia Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - AKBA (PR Newswire)
23.03.22	ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AKBA (PR Newswire)
16.03.22	AKBA EQUITY ALERT: ROSEN, A LEADING LAW FIRM, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AKBA (PR Newswire)
28.02.22	Biotech Stocks Facing FDA Decision In March 2022 (RTTNews)
05.08.21	Akebia Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Company Milestones (PR Newswire)
26.07.21	Akebia Therapeutics to Report Second Quarter 2021 Financial Results and Discuss Recent Business Highlights (PR Newswire)
01.07.21	Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
19.11.20	Pre-market Movers In Healthcare Sector: APVO, CORT, TTNP, BLU, MGTX... (RTTNews)
12.10.20	Pre-market Movers In Healthcare Sector: IMRN, AKBA, MDGS, ENLV... (RTTNews)
03.09.20	Akebia: Vadadustat Trial Achieves Efficacy Endpoints; Fails To Meet Primary Safety MACE Endpoint (RTTNews)
06.05.20	ARDS In COVID-19 Battle, AKBA's Kidney Disease Drug Hits Goals, VAPO On A Roll (RTTNews)
05.05.20	Stock Alert: Akebia Therapeutics Up 25% As Drug Trial Achieves Positive Results (RTTNews)
21.02.20	Stock To Watch: Will 2020 Be A Defining Year For Akebia (AKBA)? (RTTNews)
11.09.19	5 Top Gainers In Healthcare Sector (MNK, ENDP, MLNT...) (RTTNews)
09.04.19	Akebia Therapeutics, Vifor Pharma Expand License Agreement For Vadadustat (RTTNews)
28.06.18	Akebia Therapeutics, Keryx Biopharma To Merge - Quick Facts (RTTNews)
10.11.17	SAGE Goes Out On A High Note, MRNS Spirited, STAAR Shines, OPK Slumps (RTTNews)
29.09.17	PTCT's Quest For Approval Of DMD Drug Translarna (RTTNews)
27.09.17	AKBA Hits New 52-week High, PMD Launches Hair Test, Mateon Runs Out Of FOCUS (RTTNews)
11.09.17	Stocks Under Scanner in the Biotech Space -- Acorda Therapeutics, Advaxis, Xbiotech, and Akebia Therapeutics (PR Newswire)
29.06.17	Akebia Therapeutics Prices Offering At $14.50/Share (RTTNews)
09.06.17	Technical Insights on Biotech Stocks -- Soligenix, Sorrento Therapeutics, Alcobra, and Akebia Therapeutics (PR Newswire)
17.05.17	Gainers & Losers Of May 16: AKBA, MTFB, TTNP, IMUC, CAPR... (RTTNews)
16.05.17	AKBA Abuzz, ANTH On Track For RESULT, IMUC Faces Cash Crunch, IONS Falls (RTTNews)
27.04.17	Gainers & Losers Of Apr.26: AKBA, FLKS, BIOL, BABY, FLXN... (RTTNews)
26.04.17	AKBA Jumps On Otsuka Deal, MNOV Abuzz, CAPR Counting On HOPE... (RTTNews)
08.03.17	Gainers & Losers Of Mar.7: AUPH, KURA, TEAR, AXSM, AKBA... (RTTNews)
21.12.16	AKBA Inks Blockbuster Deal, AGN On Buying Spree, TSRO Gets FDA Date (RTTNews)
10.03.16	It's One Up For AKBA, CYNA Under Close Watch, Busy Days Ahead For APRI (RTTNews)
07.10.15	ADXS Plunges On Clinical Hold, AVXL Prepares For Uplisting, Nu Skin Peeling Off (RTTNews)
10.09.15	RVNC Works It Out, ONCE Awaits Data, AKBA, VTAE Make Big Moves, TTPH Doused (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’273.50	0.51 %	K V
Logitech Intl	75.16	0.40 %	K V
Holcim	89.10	0.27 %	K V
Alcon	76.52	0.26 %	K V
Kuehne+Nagel Int	203.10	0.25 %	K V
Sika	224.00	-0.97 %	K V
Swisscom	502.00	-0.99 %	K V
Swiss Re	130.00	-1.48 %	K V
Givaudan	4’000.00	-1.50 %	K V
Nestle	73.98	-1.65 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Akebia Therapeutics Inc

Aktien Top/Flop

Meistgelesene Nachrichten